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ABSTRACT: Preventing pregnancy in brucellosis-infected bison (Bison bison) provides a potential
means of preventing transmission of disease. To determine whether a gonadotropin-releasing
hormone (GnRH) vaccine was effective in reducing pregnancy in bison and to study the safety
of injecting GnRH in pregnant bison, a study was conducted at the Idaho Fish and Game Wildlife
Health Laboratory in Caldwell, Idaho (USA). Four pregnant and two nonpregnant female bison
were given a single injection of GnRH vaccine, and five pregnant adult females were given a
sham injection that contained only adjuvant. Three of the GnRH-vaccinated bison that were
pregnant at the time of vaccination delivered healthy calves. One treated bison had dystocia that
resulted in a dead calf. All control bison delivered healthy calves. After calving, females of both
groups were exposed to two bulls. Treated bison were palpated 6 wk after exposure to the bulls,
and blood was drawn for pregnancy-specific protein B analysis. The six treated bison were not
pregnant. The sham-treated bison became pregnant and delivered viable calves. This study demonstrates that a single dose of GnRH vaccine is effective in preventing pregnancy in female bison
for at least 1 yr.
Key words: Gonadotropin-releasing hormone, immunocontraception, GnRH vaccine, bison.

INTRODUCTION

Bovine brucellosis, a bacterial disease
caused by Brucella abortus, is transmitted
among animals, including cattle, bison (Bison bison), and elk (Cervus elaphus), primarily through contact with infected
aborted fetuses, placentas, parturient fluids, or postparturient uterine discharge.
Additionally, Brucella is shed in milk from
infected dams and can be transmitted to
calves through suckling. After initial infection, a dam often experiences abortion.
Subsequent pregnancies may result in
abortion or the birth of weak or normal
calves and may also result in the shedding
of B. abortus. The occurrence of venereal
transmission of brucellosis in bison is unknown; however, on the basis of a single
study in bison (Robison et al., 1998) and
studies in cattle (Manthei et al., 1950;
Rankin, 1965), it is considered unlikely to
be a significant route of transmission.
Transmission of the disease in cattle, bison, and elk, therefore, is primarily depen725

dent on the occurrence of pregnancy and
exposure to abortion or calving in infected
animals.
Rhyan et al. (2002) suggested that permanent sterilization, surgical or chemical,
is a disease-management strategy that
could be effectively used in Brucella-infected bison to greatly reduce the possibility of transmission to other animals. Bison cows could remain persistently infected with B. abortus, and, as long as the infected animals were not allowed to
become pregnant, they would not be likely
to transmit the infection. Therefore, disease prevalence might decrease dramatically as that generation of infected bison
disappears. Objections have been raised to
permanent sterilization in relation to wild
horse immunocontraception, because it
might result in the permanent removal of
those animals from the gene pool and the
creation of a new ‘‘unnatural’’ class of animals (Kirkpatrick and Turner, 1991).
The gonadotropin-releasing hormone

726

JOURNAL OF WILDLIFE DISEASES, VOL. 40, NO. 4, OCTOBER 2004

(GnRH) vaccine is generally considered to
provide temporary sterilization, because
the reproductive activity of the target animal returns as the GnRH antibody titer
drops below a protective level. This temporary period of infertility may allow time
for B. abortus infection to clear.
The use of nonlethal methods to control
populations of pest animals is an area of
research that is receiving more interest
(Fagerstone et al., 2002). Kirkpatrick et al.
(1996) pioneered the use of porcine zona
pellucida (PZP) for use as a nonlethal,
contraceptive approach to pest animal
control. The difficulty with the use of PZP
in ungulates is that the animals that receive it, although they remain infertile,
continue to have estrous cycles. Female
white-tailed deer (Odocoileus virginianus)
vaccinated with PZP have continued to exhibit sexual activity into February, 4 mo
beyond the normal breeding season (Miller et al., 2000b). This continuous estrous
cycling results in increased activity during
early winter, at a time when the conservation of calories is important, although
this increased cycling has not resulted in
any apparent health problems (Miller et
al., 2001). Additionally, it could increase
the spread of venereally transmitted diseases, if present and, at least in the case
of deer in populated areas, may contribute
to increased collisions with automobiles.
Prolonging the breeding season of bison in
the greater Yellowstone area may be deleterious to the winter survival of dominant
bulls and vaccinated cows because of increased activity during fall and early winter.
Immunocontraception using the GnRH
vaccine is an alternative to PZP that would
not extend the breeding season. The keyhole limpet hemocyanin–GnRH immunocontraceptive vaccine interferes with the
release of follicle-stimulating hormone
(FSH) and leutinizing hormone (LH),
thereby preventing normal function of the
ovaries and testes and their production of
progesterone and testosterone. Thus,
GnRH vaccine can effectively prevent

conception in either females or males (Talwar, 1985).
The GnRH vaccine has successfully produced sterility in Norway rats (Rattus
norvegicus; Miller et al., 1997) and whitetailed deer (Miller et al., 2000a). The immunoneutralization of GnRH produces
temporary nonsurgical castration in animals (Meloen et al., 1994; Oonk et al.,
1998). In an ongoing study in female
white-tailed deer conducted by the National Wildlife Research Center (Fort Collins, Colorado, USA) and Pennsylvania
State University (University Park, Pennsylvania, USA), a single injection of GnRH
vaccine resulted in infertility lasting up to
3 yr.
The development of immunocontraceptives that are practical to use for wildlife
population control must include vaccine
delivery systems. Although the administration of an oral form of the vaccine may be
necessary in some situations, a long acting
single-shot injectable form of the vaccine
would have practical advantages over formulations that require two injections. Immunocontraception has typically required
at least two doses, given as a prime and a
boost. The prime dose prepares the immune system for a repeat antigen exposure
and provides only a short-term immune
response. The boost immunization can result in an immune response that may last
for months to years. To have success with
a single injection, the dose and timing of
the injection is more critical than when using two injections. This article reports on
the immunocontraception of penned bison
using the newly developed single-shot
GnRH vaccine.
MATERIALS AND METHODS

On 6 June 2002, six 6-yr-old female bison
were injected with 1,800 mg of a single-shot
GnRH vaccine (GonaCon/AdjuVacTM, developed by the National Wildlife Research Center,
United States Department of Agriculture, Animal Plant Health Inspection Service, Fort Collins, Colorado—patent pending) in a 1-ml injection given intramuscularly in the hip. Five
control bison were injected with the adjuvant,
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TABLE 1.

Results of contraception in female bison using a GnRH vaccine.
Year 1

Treatment

Pregnancy status when
injected (June 2002)

Sham injection

5/5

1,800 mg GnRH/
AdjuVacb

4/6

a
b
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Year 2
Calving dates,
2002

20 June–
26 July
28 June–1
July

Pregnancy
rate

5/5
0/6

PSPBa results

5/5 positive
for pregnancy
0/6 positive
for pregnancy

Calving dates,
2003

4 June–29
July
No calves
born

PSPB 5 pregnancy-specific protein B.
GonaCon/AdjuVac, US Department of Agriculture, Animal Plant Health Inspection Service, patent pending.

1 ml, in the hip (control). All control bison and
four of the treated bison were pregnant at the
time of the injection. Because the GnRH vaccine has the potential to cause abortion, the
pregnant bison were vaccinated to determine
the safety of the GnRH vaccine. Blood samples
were drawn monthly for 4 mo and then every
other month for a total of 8 mo. Serum was
tested for progesterone by radioimmunoassay
and for GnRH antibody by enzyme-linked immunoassay (Miller et al., 2000a).
Two months after calving, a bull was introduced to the pen and allowed to breed the
cows for 2.5 mo (17 September–1 December
2002). Six weeks after the bull was removed,
both control and GnRH-treated bison were
palpated for pregnancy diagnosis, and results
were confirmed by serum pregnancy-specific
protein B assay (PSPB) testing (Biotracking,
Moscow, Idaho).
RESULTS

Analysis of pregnancy and calving data
in the control and GnRH-treated bison at
the time of GnRH injection and the following year indicated that the GnRH vaccine was successful in reducing reproduction, compared with controls (Table 1). At

FIGURE 1. Average serum progesterone levels and
anti-GnRH antibody titers for control bison cows.

the time of vaccination, five of the shamtreated cows and three of the six GnRHtreated cows were in the last month of
pregnancy. Cows in both groups delivered
normal calves the first year; therefore, the
GnRH vaccine did not interfere with the
pregnancy. None of the GnRH-treated
cows became pregnant the year after the
vaccination. All control bison conceived,
and four had normal calves, with calving
dates of 4–30 June 2003. One control cow
died on 30 March 2003 but was pregnant
at the time of death. During this study, two
cows, one each in the treated and control
groups, had dystocia that resulted in dead
calves.
The average progesterone levels for
pregnant cows were the same for the treatment and control groups at the start of the
study and after calving. After rebreeding,
the progesterone level of cows in the control group increased to pretreatment levels, indicating that they became pregnant,
and anti-GnRH titers were not detected
(Fig. 1). Progesterone levels in the GnRHtreated bison remained at nonpregnant
levels (Fig. 2). All control bison delivered
normal healthy calves and became pregnant again the second year. One of the five
control bison died from accidental causes
midgestation. The remaining four controls
had normal calves in year 2 of the study.
Three of the six GnRH-treated bison
were in late gestation when they were immunized, and all delivered normal calves
within 1 mo after treatment. Two of the
GnRH-treated cows were not pregnant at
the time of GnRH vaccination, as suggest-

728

JOURNAL OF WILDLIFE DISEASES, VOL. 40, NO. 4, OCTOBER 2004

FIGURE 2. Average anti-GnRH antibody titers and
serum progesterone levels in bison cows vaccinated
late during pregnancy.

FIGURE 3. Average anti-GnRH antibody titers and
serum progesterone levels in bison cows vaccinated
when not pregnant.

ed by low progesterone levels at the time
of treatment (Fig. 3). The low progesterone values during the postpartum period
in the cows that calved were comparable
to those of the control cows. However,
they did not become pregnant after exposure to the bulls, as indicated by low
progesterone levels, the absence of a fetus
on palpation, and negative PSPB serum
test results.
An exception to the results of treatment
of cows during late pregnancy was bison
B-40, which had been given the GnRH
vaccine during midpregnancy. This bison
cow was injected with the vaccine on 6
June 2002 and delivered full term on 6
November 2002, with dystocia, resulting in
a dead calf. The progesterone level progressively dropped from 7.0–3.5 mg/ml of
serum during the first 2 mo after vaccination and leveled off at 3.4 mg/ml of serum during the third month, 2 mo before
the birth of the dead full-term calf. This
cow had a positive PSPB result, low progesterone levels, and was not pregnant on
palpation.
The anti-GnRH data in treated bison indicated that a protective antibody titer was
reached by the first time blood was collected (47 days after vaccination). The
mean titer at this time was 112,000, decreasing to a mean titer of 72,000 by the
end of the study. Antibody titers of 64,000
or greater have been shown to be consistent with contraception (Miller et al.,
2000a).

In the beginning of the study, similar
progesterone and PSPB levels in control
and treated groups suggested that cows in
both groups were pregnant. Calving dates
were comparable in the control and treated cows, indicating synchronous breeding
cycles (Table 1). However, in the second
year, elevations in progesterone levels in
the control group suggested that they became pregnant, and low progesterone levels in the treated group suggested infertility (Figs. 1–3).
DISCUSSION

The GnRH vaccine induces infertility in
female mammals by reducing the release
of FSH and LH, which, in turn, interferes
with either the normal estrous or ovulatory
cycle or reduces progesterone concentration during early pregnancy, which may interfere with maintenance of pregnancy.
Stevenson (1997) stated that GnRH controls the amount of progesterone produced by the corpus luteum (CL), which
maintains pregnancy for 200 days of the
mean 280-day gestation in cattle. After 200
days, the ovary containing the CL can be
removed without interfering with pregnancy, which indicates that pregnancy is not
maintained by pituitary GnRH; the placenta apparently takes over the production
and maintenance of progesterone. Bison
have a gestation period similar to that of
cattle.
Our results indicate that the GnRH vaccine can be administered safely during the
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last third of pregnancy. Protective levels of
anti-GnRH antibody require 30–45 days to
develop, which suggests that the vaccine
could be safely administered at $170 days
of gestation without negative effects on the
fetus. This was shown to be the case in the
three bison treated late in pregnancy.
One cow was vaccinated during the second trimester of pregnancy and delivered
a full-term dead calf on 6 November. It is
unknown whether the GnRH vaccine contributed to death the fetus. There was a
decrease in progesterone levels in this cow
after vaccination that could have contributed to the loss of viability of the calf. Because the bull was with the cows from 17
September to 1 December, it is unlikely
that this cow could have rebred. However,
anti-GnRH antibody titers were sufficient
in this cow to prevent pregnancy. One control bison also had a similar late full-term
dead calf; thus, it is uncertain whether the
vaccine caused the death of the calf in the
vaccinated cow.
All control and treated cows were tested
for pregnancy by palpation and serum progesterone and PSBP levels during February 2003. Bison B-40 had a positive serum
PSPB test at this time but a low progesterone level and was not pregnant on palpation. Thus, the PSPB test was incorrect.
This is consistent with reports that retained placentas following abortions can
cause a false-positive PSPB result for several months (Sasser et al., 1986). The bison will be monitored for 2 more years to
determine the duration of the contraceptive effect.
This study demonstrates that a single injection of GnRH vaccine is effective in
preventing contraception in female bison
for at least 1 yr. Booster injections lengthen the contraceptive effect in white-tailed
deer (Miller and Killian, 2000), and
lengthening the contraceptive effect in bison may be achieved similarly. Use of the
GnRH vaccine in Brucella-infected bison
should effectively reduce transmission of
disease by reducing pregnancy rates and
subsequent abortion or parturition.

729

LITERATURE CITED
FAGERSTONE, K. A., M. A. COFFEY, P. B. CURTIS, R.
A. DOLBEER, G. J. KILLIAN, L. A. MILLER, AND
L. M. WILMONT. 2002. Wildlife contraception.
Wildlife Society Technical Review 02–2. 29 pp.
KIRKPATRICK, J. F., AND J. W. TURNER, JR. 1991. Reversible contraception in non-domestic animals.
Journal of Zoo and Wildlife Diseases 22: 392–
408.
,
, I. K. LIU, AND R. FAYRER-HOSKEN.
1996. Applications of pig zona pellucida immunocontraception to wildlife fertility control. Journal of Reproduction and Fertility Supplement
50: 183–189.
MELOEN R. H., J. A. TURKSTRA, H. LANKHOF, W. C.
PUIJK, W. M. M. SCHAAPER, G. DIJKSTRA, C. J.
G. WENSING, AND R. B. OONK. 1994. Efficient
immunocastration of male piglets by immunoneutralization of GnRH using a new GnRH-like
peptide. Vaccine 12: 741–746.
MANTHEI, C. A., D. E. DETRAY, AND E. R. GOODE.
1950. Brucella infection in bulls and the spread
of brucellosis in cattle by artificial injection. Proceedings of the American Veterinary Medical Association 87: 177–184.
MILLER, L. A., AND G. J. KILLIAN. 2000. Seven years
of white-tailed deer immunocontraception research at Penn State University: A comparison of
two vaccines. Ninth Eastern Wildlife Damage
Management Conference, State College, Pennsylvania, pp. 60–69.
, B. E. JOHNS, D. J. ELIAS, AND K. A. CRANE.
1997. Comparative efficacy of two immunocontraceptive vaccines. Vaccine 15: 1858–1862.
,
, AND G. J. KILLIAN. 2000a. Immunocontraception of white-tailed deer with GnRH
vaccine. American Journal of Reproductive Immunology 44: 266–274.
,
, AND
. 2000b. Long-term effects of PZP immunization on reproduction in
white-tailed deer. Vaccine 18: 568–574.
, K. CRANE, S. GADDIS, AND G. J. KILLIAN.
2001. Porcine zona pellucida immunocontraception: Long-term health effects on white-tailed
deer. Journal of Wildlife Management 65: 941–
945.
OONK, H. B., J. A. TURKSTRA, W. SCHAAPER, M. ERKENS, M. H. SCHUITEMAKER-DEWEERDM, J. H.
M. VAN NES VERHEIJDEN, AND R. H. MELOEN.
1998. New GnRH-like peptide construct to optimize efficient immunocastration of male pigs by
immunoneutralization of GnRH. Vaccine 16:
1074–82.
RANKIN, J. E. F. 1965. Brucella abortus in bulls: A
study of twelve naturally-infected cases. Veterinary Record 77:132–135.
RHYAN, J. C., AND M. D. DREW. 2002. Contraception: A possible means of decreasing transmission
of brucellosis in bison. In Brucellosis in elk and

730

JOURNAL OF WILDLIFE DISEASES, VOL. 40, NO. 4, OCTOBER 2004

bison in the Greater Yellowstone Area, T. J.
Kreeger (ed.). Greater Yellowstone Interagency
Brucellosis Committee, Wyoming Game and
Fish Department, Cheyenne, Wyoming, pp. 99–
108.
ROBISON, C. D., D. S. DAVIS, J. W. TEMPLETON, M.
WESTHUSIN, W. B. FOXWORTH, M. J. GILSDORF,
AND L. G. ADAMS. 1998 Conservation of germ
plasma from bison infected with Brucella abortus. Journal of Wildlife Diseases 34: 582-589.
SASSER, R. G., C. A. RUDER, K. A. IVANI, J. E. BUTLER, AND W. C. HAMILTON. 1986. Detection of

pregnancy by radio immunoassay of a novel pregnancy-specific protein in serum of cows and a
profile of serum concentration during gestation.
Biology of Reproduction 35: 936–942.
STEVENSON, J. S. 1997. Clinical practice in large animals. In Current therapy in large animal theriogenology, R. S. Youngquist (ed.). W.B. Saunders
Co.
TALWAR, G. P. 1985. Immunobiology of gonadotropin-releasing hormone. Journal of Steroid Biochemistry 23: 795–800.
Received for publication 29 January 2004.

